Other side effects include headache, fatigue, and dizziness
Several important considerations apply: Individuals with active or severe gastrointestinal disease may experience worsening symptoms due to the gastrointestinal side effects of GLP-1 medications The slowed gastric emptying caused by these drugs could theoretically exacerbate symptoms in people with strictures or obstructive complications of Crohn's disease Weight loss associated with GLP-1 therapy may be inappropriate in patients with Crohn's disease who are already experiencing malnutrition or unintentional weight loss The interaction between GLP-1 medications and the inflammatory processes in IBD is not fully understood Clinical decision-making should involve a thorough assessment of disease activity, nutritional status, presence of complications (such as strictures or fistulas), and the primary indication for GLP-1 therapy
Studies have shown significant weight loss (around 5-15% of body weight) in individuals using semaglutide for weight management
Responsive Service Questions answered quickly by knowledgeable staff
After taking it, you must again wait that crucial 30-60 minute period before eating your next meal
Each batch is handled according to internal quality standards designed to support consistency, verification, and controlled research workflows